Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Orchard Hill Reports a 10% Stake in Supernus Pharmaceuticals

Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained 3.5 million shares, a new filing with the SEC stated. Orchard Hill holds 10.2% of the company.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

Disclosure: none

Recommended Reading:

Mason Hawkins, Southeastern Asset Management Up Stake in Guinness Peat

4 Videos of Warren Buffett on Piers Morgan That Will Make Your Morning

Billionaire Ken Fisher’s 3 Top Stock Picks